View an enhanced version of our Special Meeting
Proxy Statement.
* Request paper copies of the above proxy materials online now, by email or by phone by dialing 866-648-8133.
Please vote your proxy online now or by phone by dialing 866-229-3489.
August 4, 2022
9:00 AM ET
You must register to be eligible to participate in the meeting.
Register By:
August 3, 2022 at 5:00 PM ET
Allena Pharmaceuticals is a late-stage biopharmaceutical company deploying its novel oral biologic platform to discover, develop and commercialize first-in-class, oral enzyme therapeutics for difficult-to-treat metabolic diseases. Allena is focused on metabolic disorders that result in excess accumulation of certain metabolites, such as oxalate and urate, that can cause kidney stones, damage the kidney, and potentially lead to chronic kidney disease, or CKD, and end-stage renal disease.
